Akubio

www.akubio.com

Akubio Limited develops and provides systems for real time analysis of biomolecular behaviour, using acoustic detection technology. Its proprietary RAP technology provides robust, cost-effective class leading sensitivity for the detection and measurement of protein and small molecule interactions.

It is privately owned, backed by a number of investors. The principal shareholding is owned by Abingworth Management Ltd, a leading UK based venture capital company specialising in unquoted Life Science companies, and named European Venture Capital Company of the Year 2004.

Other shareholdings are held by GlaxoSmithKline, Cambridge University, the Cambridge Challenge Fund, the founders, employees, and other individuals.

Staff

Contact details

181 Cambridge Science Park
Cambridge
CB4 0GJ
United Kingdom
Tel: +44(0)1223 225 335
Fax: +44(0)1223 225 336
Articles relating to Akubio

News briefs: Amino rejects patent breach claim; NextGen raises £1.5m
Subscribe

 

Corporate profiles

 • HFL


Dr Steve Pleasance
Director of Contract Research


HFL is the UK's pre-eminent sports drug surveillance and pharmaceutical contract research organisation. It has a track record in delivery for the pharma industry and world-class accredited laboratories and logistics. Its contract research services enable pharmaceutical, biotechnology, and healthcare

[HFL's profile]


Top20 Index




Currently: 71.78


Create Publisher Site
This Publisher Website ( slot3.siliconfenbusiness.com ) does not exist in Direct-Link-Ads.com. Please create it now.